These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 2989772)

  • 41. Radiotherapy systems using proton and carbon beams.
    Jongen Y
    Bull Mem Acad R Med Belg; 2008; 163(10-12):471-8; discussion 479-80. PubMed ID: 20120253
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Effects of 70 Me V proton beam on a murine tumor and skin (author's transl)].
    Majima H; Ando K; Koike S; Furukawa S; Hiraoka T; Kawachi K; Kanai T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1982 Mar; 42(3):308-16. PubMed ID: 6287406
    [No Abstract]   [Full Text] [Related]  

  • 43. Review of relative biological effectiveness dependence on linear energy transfer for low-LET radiations.
    Hunter N; Muirhead CR
    J Radiol Prot; 2009 Mar; 29(1):5-21. PubMed ID: 19225189
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effect of misonidazole in combination with radiation dose fractionation.
    Hill RP; Bush RS
    Br J Cancer Suppl; 1978 Jun; 3():255-8. PubMed ID: 277242
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The interaction of hyperthermia with fast neutrons or x rays on local tumor response.
    Hahn EW; Canada TR; Alfieri AA; McDonald JC
    Radiat Res; 1976 Oct; 68(1):39-56. PubMed ID: 823594
    [No Abstract]   [Full Text] [Related]  

  • 46. A review of the USAF/NASA proton bioeffects project: rationale and acute effects.
    Dalrymple GV; Lindsay IR; Mitchell JC; Hardy KA
    Radiat Res; 1991 May; 126(2):117-9. PubMed ID: 1850846
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dose fractionation studies with a murine sarcoma under conditions of air or carbogen (95% O2 + 5% CO2) breathing.
    Hill RP; Bush RS
    Int J Radiat Oncol Biol Phys; 1977; 2(9-10):913-9. PubMed ID: 591408
    [No Abstract]   [Full Text] [Related]  

  • 48. The influence of hemoglobin level on radiobiological hypoxia in tumors.
    Hirst DG; Brown JM
    Adv Exp Med Biol; 1986; 200():603-8. PubMed ID: 3799352
    [No Abstract]   [Full Text] [Related]  

  • 49. Re: Tumor cure studies on the rat sarcoma BA1112 using continuous low-dose-rate radiation.
    Moore JV
    Radiology; 1985 Jun; 155(3):837-8. PubMed ID: 4001394
    [No Abstract]   [Full Text] [Related]  

  • 50. Long-term outcomes of patients with unresectable benign meningioma treated with proton beam therapy.
    Sato H; Mizumoto M; Okumura T; Sakurai H; Sakamoto N; Akutsu H; Ishikawa E; Tsuboi K
    J Radiat Res; 2021 May; 62(3):427-437. PubMed ID: 33855438
    [TBL] [Abstract][Full Text] [Related]  

  • 51. IL-17 receptor-based signaling and implications for disease.
    Li X; Bechara R; Zhao J; McGeachy MJ; Gaffen SL
    Nat Immunol; 2019 Dec; 20(12):1594-1602. PubMed ID: 31745337
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The major DNA repair pathway after both proton and carbon-ion radiation is NHEJ, but the HR pathway is more relevant in carbon ions.
    Gerelchuluun A; Manabe E; Ishikawa T; Sun L; Itoh K; Sakae T; Suzuki K; Hirayama R; Asaithamby A; Chen DJ; Tsuboi K
    Radiat Res; 2015 Mar; 183(3):345-56. PubMed ID: 25738894
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sinonasal malignancies and charged particle radiation treatment: a systematic literature review.
    Cianchetti M; Amichetti M
    Int J Otolaryngol; 2012; 2012():325891. PubMed ID: 22693516
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Proton beam therapy for hepatocellular carcinoma patients with severe cirrhosis.
    Hata M; Tokuuye K; Sugahara S; Fukumitsu N; Hashimoto T; Ohnishi K; Nemoto K; Ohara K; Matsuzaki Y; Akine Y
    Strahlenther Onkol; 2006 Dec; 182(12):713-20. PubMed ID: 17149578
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Proton therapy in Japan.
    Tsunemoto H; Morita S; Ishikawa T; Furukawa S; Kawachi K; Kanai T; Ohara H; Kitagawa T; Inada T
    Radiat Res Suppl; 1985; 8():S235-43. PubMed ID: 3003785
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The relative biological effectiveness of the modulated proton beam at TRIUMF.
    Nemoto K; Pickles T; Minchinton AI; Lam GK
    Radiat Med; 1998; 16(1):43-6. PubMed ID: 9568632
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Determination of the contribution of gamma radiation to absorbed dose and the radiobiological effects in the radiation field resulting from the reaction p(50MeV)--Be].
    Bukanov VN; Kataevskiĭ IuF; Indyk VM; Chebotarev EE; Tkachenko NA
    Radiobiologiia; 1983; 23(4):565-8. PubMed ID: 6310677
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Modelling carcinogenesis after radiotherapy using Poisson statistics: implications for IMRT, protons and ions.
    Jones B
    J Radiol Prot; 2009 Jun; 29(2A):A143-57. PubMed ID: 19454805
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Relative biological effectiveness of the therapeutic proton beams at NIRS and Tsukuba University].
    Ando K; Koike S; Kawachi K; Hiraoka T; Ohara H; Yokota M; Inada T; Hirokawa Y; Sato S; Eguchi K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1985 Mar; 45(3):531-5. PubMed ID: 2989772
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.